Anthem Biosciences Limited

₹942.35As of Sun 8 Nov 2026, 12:00 UTC
NSE:ANTHEMHealthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR —
Div yield 0.21%
ROE 20.35%
Biotechnology
Beta (5Y) —
PE TTM 87.09
TSR TTM 33.05%
Mkt cap ₹530.7B
ROIC 21.77%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹1,155
22.52%
(88.20%)
Hold 10|0|2|0|1
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
19.01
18.48
20.31
20.44
7.80%
5.22%
4.72%
8.26%
Revenue₹B
29.51
28.90
28.33
28.50
4.65%
3.02%
1.11%
1.25%
Peers (US$5.487B)
Cap (US$)
PE
6.330B
124.2x
Capital
TTM
5Y
10Y
Leveragex
1.276
(0.080)
(0.086)
EBIT/Intx
1.120
0.258
0.258
Own earn%
33.14
86.16
71.17
Sh yield%
20.30
28.35
27.60
Owners
Insiders/Inst%
10.26
41.23
Short interest%
1.90
SBC / revenue%
5.78
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
20–26
$1 testx
—
Incr. ROIC%
10